As well as research into primary immunodeficiencies, it is also conducting research to identify molecular bases in cases of less serious combined immunodeficiencies that have not yet been characterised by exogenous analysis or high-performance sequencing techniques, next generation sequencing (NGS). The group is jointly responsible for implementing the RAPID programme (Rapid and Advanced diagnosis and treatment of Primary ImmunoDeficiencies), which includes the use of NGS to reduce the time between clinical suspicion and genetic diagnosis. An example of collaboration between the Hospital, the Vall d’Hebron Research Institute and the BST (Banc de Sang i de Teixits - Blood and Tissue Bank) to coordinate all the stages in managing patients with these pathologies.
The group is also working in connection with other research groups and with industry to identify better biomarkers for a variety of immune-mediated diseases in order to evaluate therapeutic activity and response in autoimmune diseases.
This group coordinates the Barcelona-UAB-Focis (Federation of Clinical Immunology Societies) Centre of Excellence.